RIFINAH Side Effects

6800762-X | Arthralgia, Haemarthrosis, Paraesthesia, Tendon Rupture
on Jun 25, 2010 Female patient from FRANCE , 46 years of age, weighting 180.8 lb, was diagnosed with tuberculosis (What is tuberculosis?), pain (What is pain?) and was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, haemarthrosis, paraesthesia, tendon rupture. Rifinah dosage: Dose:2 Unit(s). During the same period patient was treated with TOPALGIC (View Topalgic Review and Topalgic Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ).

6751118-X | Oesophagitis, Photosensitivity Reaction
Patient was taking Rifinah (View Usage). Patient had the following side effects: oesophagitis, photosensitivity reaction on Jun 01, 2010 from FRANCE Additional patient health information: Female patient , 46 years of age, was diagnosed with pulmonary tuberculosis and. Rifinah dosage: Dose:2 Unit(s). During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), ISONIAZID (Dose:2 Unit(s)) (View Isoniazid Review and Isoniazid Label ), DEXAMBUTOL (View Dexambutol Review and Dexambutol Label ), RIMIFON (View Rimifon Review and Rimifon Label ). Patient was hospitalized.

6695911-0 | Insomnia, Psychomotor Hyperactivity
Adverse event was reported on Apr 20, 2010 by a Female patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: FRANCE , 51 years of age, weighting 154.3 lb, After Rifinah was administered, patient had the following side effects: insomnia, psychomotor hyperactivity. During the same period patient was treated with MS CONTIN (View Ms Contin Review and Ms Contin Label ), COKENZEN (View Cokenzen Review and Cokenzen Label ), XANAX (View Xanax Review and Xanax Label ), AMILORIDE HCL AND HYDROCHLOROTHIAZIDE (View Amiloride Hcl And Hydrochlorothiazide Review and Amiloride Hcl And Hydrochlorothiazide Label ). Patient was hospitalized.

6682436-1 | Psoriasis
on Apr 09, 2010 Female patient from SPAIN , 54 years of age, was diagnosed with antibiotic prophylaxis and was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: psoriasis. Rifinah dosage: .


6576741-7 | Abnormal Behaviour, Agitation, Insomnia, Psychotic Disorder
on Feb 02, 2010 Female patient from UNITED KINGDOM , 31 years of age, was diagnosed with latent tuberculosis and was treated with Rifinah (View Usage). Patient had the following side effects: abnormal behaviour, agitation, insomnia, psychotic disorder (What is psychotic disorder?). Rifinah dosage: .

6298171-8 | Henoch-schonlein Purpura, Vascular Purpura
Patient was taking Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: henoch-schonlein purpura, vascular purpura on Jul 27, 2009 from Additional patient health information: Male patient , 28 years of age, was diagnosed with pulmonary tuberculosis and. Rifinah dosage: . Patient was hospitalized.

6181345-4 | Abdominal Pain Upper, Fat Intolerance, Gastrooesophageal Reflux Disease, Myalgia, Nausea, Vertigo, Weight Decreased
Adverse event was reported on Apr 27, 2009 by a Female patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with tuberculosis (What is tuberculosis?) and. Location: FRANCE , 27 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, fat intolerance, gastrooesophageal reflux disease, myalgia, nausea (What is nausea?), vertigo, weight decreased.

6164902-0 | Irritability, Paraesthesia, Tremor, Weight Decreased
on Apr 14, 2009 Female patient from , 22 years of age, was treated with Rifinah (View Usage). Patient had the following side effects: irritability, paraesthesia, tremor, weight decreased. Rifinah dosage: .

6119361-0 | Adrenocortical Insufficiency Acute
on Mar 05, 2009 Male patient from , 39 years of age, was diagnosed with tuberculosis (What is tuberculosis?), adrenal insufficiency and was treated with Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: adrenocortical insufficiency acute. Rifinah dosage: . During the same period patient was treated with FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), SULFARLEM /00558302/ (View Sulfarlem /00558302/ Review and Sulfarlem /00558302/ Label ). Patient was hospitalized.

6077204-8 | Cholestatic Liver Injury, Eosinophilia, Face Oedema, Hepatocellular Injury, Lymphadenopathy, Pyrexia, Rash Maculo-papular
Patient was taking Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: cholestatic liver injury, eosinophilia, face oedema, hepatocellular injury, lymphadenopathy, pyrexia, rash maculo-papular on Jan 15, 2009 from Additional patient health information: Male patient , 58 years of age, was diagnosed with pulmonary tuberculosis and. Rifinah dosage: . During the same period patient was treated with PIRILENE (View Pirilene Review and Pirilene Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LASIX (View Lasix Review and Lasix Label ), IMOVANE (View Imovane Review and Imovane Label ), INSULINE (View Insuline Review and Insuline Label ). Patient was hospitalized.

6048624-2 | Cholestatic Liver Injury, Eosinophilia, Hypersensitivity, Pericardial Effusion, Pleuropericarditis
Adverse event was reported on Jan 15, 2009 by a Female patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with arthritis (What is arthritis?) and. Location: , 58 years of age, Patient had the following side effects: cholestatic liver injury, eosinophilia, hypersensitivity, pericardial effusion, pleuropericarditis. During the same period patient was treated with CARTREX (View Cartrex Review and Cartrex Label ), OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), NEXEN (View Nexen Review and Nexen Label ), INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ). Patient was hospitalized.

6041794-1 | Asthenia, Nausea, Vertigo, Vestibular Disorder
on Jan 07, 2009 Female patient from FRANCE , 30 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: asthenia, nausea (What is nausea?), vertigo, vestibular disorder. Rifinah dosage: .

6013244-2 | Toxic Epidermal Necrolysis
on Dec 12, 2008 Female patient from , 70 years of age, weighting 123.5 lb, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Rifinah dosage: Dose: 300/450. During the same period patient was treated with STREPTOMYCIN (View Streptomycin Review and Streptomycin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ).

5920989-9 | Cholestatic Liver Injury, Eosinophilia, Face Oedema, Hepatocellular Injury, Lymphadenopathy, Pyrexia, Rash Maculo-papular
Patient was taking Rifinah (View Usage). Patient had the following side effects: cholestatic liver injury, eosinophilia, face oedema, hepatocellular injury, lymphadenopathy, pyrexia, rash maculo-papular on Oct 06, 2008 from Additional patient health information: Male patient , 58 years of age, was diagnosed with pulmonary tuberculosis and. Rifinah dosage: . During the same period patient was treated with PIRILENE (View Pirilene Review and Pirilene Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), APROVEL (View Aprovel Review and Aprovel Label ), LASIX (View Lasix Review and Lasix Label ), IMOVANE (View Imovane Review and Imovane Label ), INSULINE (View Insuline Review and Insuline Label ). Patient was hospitalized.

5802200-2 | Asthenia, Confusional State, Dyskinesia, Malaise, Visual Impairment
Adverse event was reported on Jun 25, 2008 by a Male patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?) and. Location: , 47 years of age, After Rifinah was administered, patient had the following side effects: asthenia, confusional state, dyskinesia, malaise, visual impairment. During the same period patient was treated with ACOMPLIA (View Acomplia Review and Acomplia Label ), AMARYL (View Amaryl Review and Amaryl Label ), ZANIDIP (View Zanidip Review and Zanidip Label ). Patient was hospitalized.

5751038-3 | Thrombosis
on May 20, 2008 Male patient from , 53 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis. Rifinah dosage: . During the same period patient was treated with INIPOMP /01263201/ (View Inipomp /01263201/ Review and Inipomp /01263201/ Label ), PLAVIX (View Plavix Review and Plavix Label ), ATHYMIL (View Athymil Review and Athymil Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), IMOVANE (View Imovane Review and Imovane Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), TAHOR (View Tahor Review and Tahor Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ). Patient was hospitalized.

5721025-X | Facial Palsy
on Apr 21, 2008 Female patient from , 38 years of age, was treated with Rifinah (View Usage). Patient had the following side effects: facial palsy. Rifinah dosage: .

5708047-X | Periarthritis
Patient was taking Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: periarthritis on Apr 10, 2008 from Additional patient health information: Male patient , 60 years of age, was diagnosed with pulmonary tuberculosis and. Rifinah dosage: .

5643158-9 | Dyspnoea, Nausea, Pneumonia Aspiration
Adverse event was reported on Feb 21, 2008 by a Female patient taking Rifinah (View Usage) (Dosage: ) . Location: , 84 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, nausea (What is nausea?), pneumonia aspiration. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5612647-5 | Abortion Induced, No Adverse Event
on Jan 31, 2008 Female patient from FRANCE , 31 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifinah (View Usage). Patient had the following side effects: abortion induced, no adverse event. Rifinah dosage: . Patient was hospitalized.

5534254-5 | Amenorrhoea, Dyspepsia, Weight Decreased
on Nov 29, 2007 Female patient from , 16 years of age, weighting 109.9 lb, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: amenorrhoea, dyspepsia, weight decreased. Rifinah dosage: . During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), RIFATER (View Rifater Review and Rifater Label ).

5508853-0 | Ectopic Pregnancy, Menstruation Irregular, Unintended Pregnancy, Weight Increased
Patient was taking Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: ectopic pregnancy, menstruation irregular, unintended pregnancy, weight increased on Oct 30, 2007 from Additional patient health information: Female patient , 27 years of age, was diagnosed with tuberculosis (What is tuberculosis?), contraception and. Rifinah dosage: . During the same period patient was treated with PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), IMPLANON (View Implanon Review and Implanon Label ).

5300455-4 | Cerebral Haemorrhage Neonatal, Shock Haemorrhagic
Adverse event was reported on Apr 04, 2007 by a Female patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with pulmonary tuberculosis and. Location: , weighting 8.82 lb, Patient had the following side effects: cerebral haemorrhage neonatal, shock haemorrhagic. During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ).

5255160-X | Angioedema, Chills, Hypotension, Pruritus, Pyrexia, Urticaria
on Feb 28, 2007 Male patient from , 43 years of age, weighting 176.4 lb, was diagnosed with cough and was treated with Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: angioedema, chills, hypotension, pruritus, pyrexia, urticaria. Rifinah dosage: . During the same period patient was treated with BIOCALYPTOL (View Biocalyptol Review and Biocalyptol Label ), DAFALGAN /00020001/ (View Dafalgan /00020001/ Review and Dafalgan /00020001/ Label ), PENTASA (View Pentasa Review and Pentasa Label ). Patient was hospitalized.

5239445-9 | Abdominal Pain, Blood Amylase Increased, Lipase Increased, Pancreatitis Acute
on Feb 13, 2007 Female patient from , 29 years of age, weighting 112.4 lb, was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood amylase increased, lipase increased, pancreatitis acute. Rifinah dosage: . Patient was hospitalized.

5203463-7 | Psoriasis, Toxic Skin Eruption
Patient was taking Rifinah (View Usage). Patient had the following side effects: psoriasis, toxic skin eruption on Jan 02, 2007 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with psoriasis and. Rifinah dosage: 2 Df Per Day. During the same period patient was treated with NEORAL (300 Mg/day) (View Neoral Review and Neoral Label ). Patient was hospitalized.

5182685-8 | Condition Aggravated, Psoriasis, Toxic Skin Eruption
Adverse event was reported on Dec 18, 2006 by a Male patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with psoriasis and. Location: , 57 years of age, After Rifinah was administered, patient had the following side effects: condition aggravated, psoriasis, toxic skin eruption. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ). Patient was hospitalized.

5166675-7 | Ageusia, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatocellular Damage, Hypoaesthesia Oral, Sjogren's Syndrome
on Oct 06, 2006 Female patient from FRANCE , 56 years of age, weighting 152.1 lb, was diagnosed with antibiotic prophylaxis and was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: ageusia, alanine aminotransferase increased, aspartate aminotransferase increased, hepatocellular damage, hypoaesthesia oral, sjogren's syndrome (What is sjogren's syndrome?). Rifinah dosage: . During the same period patient was treated with NOROXIN (View Noroxin Review and Noroxin Label ).

5129369-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatocellular Damage, Sjogren's Syndrome
on Oct 06, 2006 Female patient from FRANCE , 55 years of age, was diagnosed with antibiotic prophylaxis and was treated with Rifinah (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatocellular damage, sjogren's syndrome (What is sjogren's syndrome?). Rifinah dosage: .

5125916-2 | Alanine Aminotransferase Increased, Angioneurotic Oedema, Swelling Face, Urticaria
Patient was taking Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: alanine aminotransferase increased, angioneurotic oedema, swelling face, urticaria on Oct 03, 2006 from Additional patient health information: Male patient , 32 years of age, weighting 172.0 lb, was diagnosed with antibiotic prophylaxis and. Rifinah dosage: Dose: 2df.

5121621-7 | Immune Reconstitution Syndrome, Liver Function Test Abnormal, Rash Maculo-papular, Toxic Epidermal Necrolysis, Tuberculosis
Adverse event was reported on Sep 26, 2006 by a Female patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Location: , 43 years of age, weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, liver function test abnormal, rash maculo-papular, toxic epidermal necrolysis, tuberculosis (What is tuberculosis?). During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ETHAMBUTOL HCL (Dose: Unk) (View Ethambutol Hcl Review and Ethambutol Hcl Label ), CIPROFLOXACIN (Dose: Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), CLEXANE (Dose: Unk) (View Clexane Review and Clexane Label ), CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ), GENTAMICIN (Dose: Unk) (View Gentamicin Review and Gentamicin Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

5090055-6 | Blood Bilirubin Increased, Hepatorenal Syndrome, Icterus Index Increased, Liver Disorder, Transaminases Increased, Vomiting
on Jul 24, 2006 Female patient from NORWAY , 82 years of age, was diagnosed with tuberculous pleurisy and was treated with Rifinah (View Usage). Patient had the following side effects: blood bilirubin increased, hepatorenal syndrome, icterus index increased, liver disorder, transaminases increased, vomiting. Rifinah dosage: . During the same period patient was treated with PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), ALLOPUR (View Allopur Review and Allopur Label ), SELO ZOK (View Selo-zok Review and Selo-zok Label ), COZAAR (Dose: 50 Mg/12.5 Mg) (View Cozaar Review and Cozaar Label ).

5078234-5 | Blood Bilirubin Increased, Hepatorenal Syndrome, Icterus Index Increased, Liver Disorder, Transaminases Increased, Vomiting
on Jul 24, 2006 Female patient from NORWAY , 82 years of age, was diagnosed with pleurisy, tuberculosis (What is tuberculosis?) and was treated with Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: blood bilirubin increased, hepatorenal syndrome, icterus index increased, liver disorder, transaminases increased, vomiting. Rifinah dosage: . During the same period patient was treated with PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), ALLOPUR (View Allopur Review and Allopur Label ), SELO ZOK (View Selo-zok Review and Selo-zok Label ), COZAAR (Dose: 50 Mg/12.5 Mg) (View Cozaar Review and Cozaar Label ).

4913741-4 | Fluid Retention, Pericardial Effusion, Pleural Effusion, Weight Increased
Patient was taking Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: fluid retention, pericardial effusion, pleural effusion, weight increased on Feb 09, 2006 from SWITZERLAND Additional patient health information: Male patient , 51 years of age, was diagnosed with essential hypertension and. Rifinah dosage: Dose: 1 Dosage Form. During the same period patient was treated with LONITEN (View Loniten Review and Loniten Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), MYFORTIC /SCH/ (View Myfortic /sch/ Review and Myfortic /sch/ Label ), COZAAR (View Cozaar Review and Cozaar Label ), BELOC (Dose: I Dosage Form) (View Beloc Review and Beloc Label ), NORVASC (View Norvasc Review and Norvasc Label ), RECORMON (View Recormon Review and Recormon Label ). Patient was hospitalized.

4871600-X | Anaphylactic Shock, Blood Creatinine Increased, Chills, Coagulation Factor V Level Decreased, Conjunctival Hyperaemia, Disseminated Intravascular Coagulation, Erythema, Haemodynamic Instability, Hepatic Failure
Adverse event was reported on Nov 25, 2005 by a Female patient taking Rifinah (View Usage) (Dosage: ) was diagnosed with tuberculin test positive, exposure to communicable disease and. Location: FRANCE , 55 years of age, weighting 198.4 lb, Patient had the following side effects: anaphylactic shock, blood creatinine increased, chills, coagulation factor v level decreased, conjunctival hyperaemia, disseminated intravascular coagulation, erythema, haemodynamic instability, hepatic failure. Patient was hospitalized.

4869292-9 | Anaemia, Hydrothorax, Renal Failure Acute, Thrombocytopenia
on Nov 29, 2005 Male patient from , 75 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Rifinah (View Usage). After Rifinah was administered, patient had the following side effects: anaemia, hydrothorax, renal failure acute, thrombocytopenia. Rifinah dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

4612592-8 | Asthenia, Chills, Hepatic Function Abnormal, Pain In Extremity
on Mar 14, 2005 Male patient from , 32 years of age, was diagnosed with infection prophylaxis and was treated with Rifinah (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chills, hepatic function abnormal, pain in extremity. Rifinah dosage: .

4555753-9 | Cerebral Haemorrhage Neonatal
Patient was taking Rifinah (View Usage). Patient had the following side effects: cerebral haemorrhage neonatal on Jan 13, 2005 from Additional patient health information: Female patient , weighting 8.82 lb, was diagnosed with pulmonary tuberculosis and. Rifinah dosage: . During the same period patient was treated with MYAMBUTOL (View Myambutol Review and Myambutol Label ).